[1]周 娟.2019-2022年南丰县肿瘤发病和死亡趋势分析[J].医学信息,2023,36(23):38-41.[doi:10.3969/j.issn.1006-1959.2023.23.009]
　ZHOU Juan.Trend Analysis of Cancer Incidence and Mortality in Nanfeng County from 2019 to 2022[J].Journal of Medical Information,2023,36(23):38-41.[doi:10.3969/j.issn.1006-1959.2023.23.009]
点击复制

2019-2022年南丰县肿瘤发病和死亡趋势分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年23期
页码:
38-41
栏目:
公共卫生信息学
出版日期:
2023-12-01

文章信息/Info

Title:
Trend Analysis of Cancer Incidence and Mortality in Nanfeng County from 2019 to 2022
文章编号:
1006-1959（2023）23-0038-04
作者:
周 娟
（南丰县疾病预防控制中心公共卫生科，江西 南丰 344500）
Author(s):
ZHOU Juan
(Deparment of Public Health,Nanfeng County Center for Disease Control and Prevention,Nanfeng 344500,Jiangxi,China)
关键词:
南丰县; 肿瘤; 发病趋势; 死亡趋势
Keywords:
Nanfeng county; Tumors; Morbidity trend; Mortality trend
分类号:
R197
DOI:
10.3969/j.issn.1006-1959.2023.23.009
文献标志码:
A
摘要:
目的 分析2019-2022年南丰县肿瘤发病和死亡趋势。方法 收集2019年1月-2022年12月南丰县登记肿瘤发病、死亡数据及人口资料，从诊断或死亡年份、性别、年龄组分层，计算数量、构成比等指标，分析该地区肿瘤发病和死亡趋势。结果 2019-2022年南丰县共纳入肿瘤发病病例2667例，2019发病率为312.26/10万，中标率为268.61/10万，2022年下降至240.49/10万、166.202/10万，下降趋势有统计学意义（P＜0.05）。男性和女性肿瘤发病率下降趋势均有统计学意义，且男性恶性肿瘤中标死亡率高于女性（P＜0.05）；2019-2022年南丰县肿瘤死亡率下降趋势有统计学意义，且0~74岁累计率高于0~64岁累计率（P＜0.05）；2019-2022年南丰县肿瘤登记地区肿瘤发病率在0~39 岁处于较低水平，40岁以后随着年龄的增长逐渐升高，55~59岁开始快速上升，75~79岁达到最高峰；死亡率在0~44岁处于较低水平，45岁以后随着年龄的增长逐渐升高，55~59岁开始快速上升，80~84岁达到最高峰。结论 2019-2022年南丰县肿瘤发病和死亡率呈逐年下降趋势，并且呈一定的年龄特点分布，应高度重视该地区的肿瘤防治，做好肿瘤筛查和早期诊断，切实改善肿瘤患者预后。
Abstract:
Objective To analyze the trend of cancer incidence and mortality in Nanfeng County from 2019 to 2022.Methods The data of cancer incidence, mortality and population in Nanfeng County from January 2019 to December 2022 were collected. The number and composition ratio were calculated from the year of diagnosis or death, gender and age group to analyze the trend of cancer incidence and mortality in this area.Results From 2019 to 2022, a total of 2667 cases of cancer were included in Nanfeng County. The incidence rate in 2019 was 312.26 / 100 000, and the ASR China was 268.61/100 000. In 2022, it decreased to 240.49/100 000 and 166.202/100 000, respectively. The downward trend was statistically significant (P<0.05). The downward trend of cancer incidence in both males and females was statistically significant, and the ASR China of malignant tumors in males was higher than that in females (P<0.05). From 2019 to 2022, the downward trend of tumor mortality in Nanfeng County was statistically significant, and the cumulative rate of 0-74 years old was higher than that of 0-64 years old (P<0.05). From 2019 to 2022, the incidence of cancer in the cancer registration area of Nanfeng County was at a low level at the age of 0-39 years old. After the age of 40, it gradually increased with age, began to rise rapidly at the age of 55-59 years old, and reached the highest peak at the age of 75-79 years old. The mortality rate was at a low level from 0 to 44 years old, gradually increased with age after 45 years old, began to rise rapidly from 55 to 59 years old, and reached the peak from 80 to 84 years old.Conclusion From 2019 to 2022, the incidence and mortality of tumors in Nanfeng County shows a downward trend year by year, and shows a certain age distribution. We should attach great importance to the prevention and treatment of tumors in this area, do a good job in tumor screening and early diagnosis, and effectively improve the prognosis of tumor patients.

参考文献/References:

[1]许可葵,王静,廖先珍,等.2017年湖南省肿瘤登记地区恶性肿瘤发病及死亡资料分析[J].肿瘤药学,2021,11(1):71-81.[2]许可葵,王静,刘湘国,等.2009~2014年湖南省肿瘤登记地区恶性肿瘤发病与死亡分析[J].中国肿瘤,2018,27(10):738-748. [3]赫捷,魏文强.2019中国肿瘤登记年报[M].北京:人民卫生出版社,2021:108-119.[4]姜帆,付振涛,陈先献,等.2016年山东省恶性肿瘤发病与死亡水平分析[J].中华肿瘤防治杂志,2021,28(11):797-804.[5]王艳平,邱琳,武萌,等.2016 年陕西省恶性肿瘤发病与死亡分析[J].实用肿瘤学杂志,2022,36(1):1-6.[6]陈琼,徐慧芳,刘曙正,等.2010-2016年河南省食管癌发病与死亡情况趋势分析[J].中华肿瘤杂志,2022,44(1):86-92.[7]李辉章,杜灵彬,朱陈,等.2000~2012年浙江省肿瘤登记地区上消化道癌发病与死亡分析[J].肿瘤预防与治疗,2018,31(1):5-11.[8]Fan X,Qin X,Zhang Y,et al.Screening for gastric cancer in China：advances,challenges and visions[J].Chin J Cancer Res,2021,33(2):168-180.[9]王建宁,潘龙海,陈志昊,等.2011年云南省个旧市恶性肿瘤发病调查研究[J].慢性病学杂志,2016,17(5):479-482[10]周浩,刘文利,于丽娅,等.2014-2019年辽宁省朝阳市城市居民肝癌死亡率年度趋势分析及灰色模型预测[J].现代预防医学,2021,48(7):1293-1297．[11]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018： GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):1-31[12]陈万青,李贺.人群肿瘤监测在癌症防控中的作用[J].肿瘤预防与治疗,2018,31(1):1-4.[13]辛雯艳,黄磊,闫贻忠.2005-2013年中国肿瘤登记地区肺癌流行和疾病负担时间趋势分析[J].中华肿瘤防治杂志,2019,26(15):1059-1065.[14]李灿,王静,廖先珍,等.2014年-2018 年湖南省肿 瘤登记地区恶性肿瘤发病与死亡特征及变化趋势分析[J].肿瘤药学,2022,12(4):528-535.[15]高从,马新颜,董会敏.2016年石家庄市肿瘤登记地区恶性肿瘤发病与死亡分析[J].肿瘤防治研究,2020,47(7):547-552.[16]于继刚,崔泽,潘利,等.河北省 20-80岁城乡汉族居民吸烟状况调查[J].中国公共卫生,2022,38(1):61-64.[17]赵仁成,雷林,蔡日东,等.2001-2015年深圳市肺癌发病特征分析[J].中国慢性病预防与控制,2019,27(6):475-478.[18]张学飞,闫贻忠,庞丽娟,等.中国老年人群恶性肿瘤疾病负担[J].中国老年学杂志,2017,37(21):5325-5329.[19]韩仁强,武鸣,缪伟刚,等.2017年江苏省恶性肿瘤流行情况分析[J].江苏预防医学,2022,33(4):390-394.[20]吴春晓,顾凯,庞怡,等.2016年上海市恶性肿瘤发病和死亡情况与 2002-2016年的 变化趋势分析[J].中国癌症杂志,2021,31(10):879-891.

相似文献/References:

[1]杨森果,毛大华,杨海松,等.E-cadherin与肿瘤侵袭、转移相关性研究进展[J].医学信息,2018,31(03):3.[doi:10.3969/j.issn.1006-1959.2018.04.002]
　YANG Sen-guo,MAO Da-hua,YANG Hai-song,et al.Research Progress of the Correlation between E-cadherin and Tumor Invasion and Metastasis[J].Journal of Medical Information,2018,31(23):3.[doi:10.3969/j.issn.1006-1959.2018.04.002]
[2]江立基,李先明.碳酸酐酶Ⅸ在肿瘤中的研究进展[J].医学信息,2018,31(03):7.[doi:10.3969/j.issn.1006-1959.2018.03.003]
　JIANG Li-ji,LI Xian-ming.Research Progress of Carbonic Anhydrase IX in Cancer[J].Journal of Medical Information,2018,31(23):7.[doi:10.3969/j.issn.1006-1959.2018.03.003]
[3]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(23):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[4]白 雪,邓 琦.血液系统肿瘤的细胞治疗研究进展[J].医学信息,2018,31(10):41.[doi:10.3969/j.issn.1006-1959.2018.10.013]
　BAI Xue,DENG Qi.Advances in Cell Therapy for Blood System Tumor[J].Journal of Medical Information,2018,31(23):41.[doi:10.3969/j.issn.1006-1959.2018.10.013]
[5]李 轩,王子为,赵靖萱,等.肿瘤预后预测领域机器学习应用的文献计量与热点可视化分析[J].医学信息,2022,35(09):90.[doi:10.3969/j.issn.1006-1959.2022.09.023]
　LI Xuan,WANG Zi-wei,ZHAO Jing-xuan,et al.Visualization Analysis on Bibliometrics and Hot Spots of Machine Learning Applications in the Field of Tumor Prognosis Prediction[J].Journal of Medical Information,2022,35(23):90.[doi:10.3969/j.issn.1006-1959.2022.09.023]
[6]王 静,刘 梅,焦菊凤.知-信-行健康教育模式对PICC置管肿瘤 患者自我护理能力的影响[J].医学信息,2018,31(11):170.[doi:10.3969/j.issn.1006-1959.2018.11.056]
　WANG Jing,LIU Mei,JIAO Ju-feng.Effect of Knowledge-belief-behavioral Health Education Model on the Self-care Ability of Patients with Cancer in PICC Catheterization[J].Journal of Medical Information,2018,31(23):170.[doi:10.3969/j.issn.1006-1959.2018.11.056]
[7]史红娟,李群锋,赵 华,等.舒林酸抗肿瘤作用的研究进展[J].医学信息,2018,31(12):35.[doi:10.3969/j.issn.1006-1959.2018.12.012]
　SHI Hong-juan,LI Qun-feng,ZHAO Hua,et al.Advances in Research on Anti-tumor Effect of Sulindac[J].Journal of Medical Information,2018,31(23):35.[doi:10.3969/j.issn.1006-1959.2018.12.012]
[8]庞小坤,韩 梅,江心灿,等.当归补血汤治疗肿瘤化疗不良反应随机对照临床试验的Meta分析[J].医学信息,2019,32(02):69.[doi:10.3969/j.issn.1006-1959.2019.02.021]
　Pang Xiao-kun,Han Mei,Jiang Xin-can,et al.Meta-analysis of a Randomized Controlled Clinical Trial of Angelica Buxue Decoction in the Treatment of Adverse Reactions to Chemotherapy[J].Journal of Medical Information,2019,32(23):69.[doi:10.3969/j.issn.1006-1959.2019.02.021]
[9]张 慧,胡广越,殷 红.菌群干预与免疫治疗的研究进展[J].医学信息,2022,35(11):54.[doi:10.3969/j.issn.1006-1959.2022.11.016]
　ZHAHG Hui,HU Guang-yue,YIN Hong.Research Progress in Microbial Intervention and Immunotherapy[J].Journal of Medical Information,2022,35(23):54.[doi:10.3969/j.issn.1006-1959.2022.11.016]
[10]郑文灿,法艳梅,吕亚青,等.苦参碱抗肿瘤机制的分子生物学研究进展[J].医学信息,2018,31(19):51.[doi:10.3969/j.issn.1006-1959.2018.19.017]
　ZHENG Wen-can,FA Yan-mei,LV Ya-qing,et al.Advances in Molecular Biology of Matrine Antitumor Mechanism[J].Journal of Medical Information,2018,31(23):51.[doi:10.3969/j.issn.1006-1959.2018.19.017]

更新日期/Last Update: 1900-01-01